Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The United Laboratories International Holdings ( (HK:3933) ) just unveiled an announcement.
The United Laboratories International Holdings Limited announced the vesting of 3,369,800 Award Shares to its executives and employees as part of the 2023 Share Award Scheme. This move reflects the company’s commitment to rewarding performance and aligning the interests of its leadership and workforce with its strategic goals.
The most recent analyst rating on (HK:3933) stock is a Hold with a HK$14.00 price target. To see the full list of analyst forecasts on The United Laboratories International Holdings stock, see the HK:3933 Stock Forecast page.
More about The United Laboratories International Holdings
The United Laboratories International Holdings Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the development, production, and sale of pharmaceutical products.
Average Trading Volume: 14,639,551
Technical Sentiment Signal: Buy
Current Market Cap: HK$25.53B
Learn more about 3933 stock on TipRanks’ Stock Analysis page.